XML 19 R6.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Series B Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total Neonode Inc. Stockholders' Equity
Noncontrolling Interests
Balances at Dec. 31, 2013 $ 6,348 $ 38 $ 157,994 $ 11 $ (151,695) $ 6,348
Balances, shares at Dec. 31, 2013   83 37,934          
Stock option compensation expense to employees, directors and vendors 1,729 1,729 1,729
Proceeds from sale of common stock and pre-funded warrants, net of offering costs 9,253 $ 2 9,251 9,253
Proceeds from sale of common stock and pre-funded warrants, net of offering costs, shares   2,500          
Common stock issued upon exercise of common stock warrants 36 36 36
Common stock issued upon exercise of common stock warrants, shares   21          
Foreign currency translation adjustment 138 138 138
Net loss (14,234) (14,234) (14,234)
Balances at Dec. 31, 2014 3,270 $ 40 169,010 149 (165,929) 3,270
Balances, shares at Dec. 31, 2014   83 40,455          
Stock option compensation expense to employees, directors and vendors 1,075 1,075 1,075
Proceeds from sale of common stock and pre-funded warrants, net of offering costs 5,422 $ 3 5,419 5,422
Proceeds from sale of common stock and pre-funded warrants, net of offering costs, shares   3,200          
Common stock issued upon exercise of common stock warrants 1 $ 1 1
Common stock issued upon exercise of common stock warrants, shares   151          
Foreign currency translation adjustment (103) (103) (103)
Noncontrolling interests Pronode initial contribution 3 3
Net loss (7,835) (7,820) (7,820) (15)
Balances at Dec. 31, 2015 1,833 $ 44 175,504 46 (173,749) 1,845 (12)
Balances, shares at Dec. 31, 2015   83 43,806          
Stock option compensation expense to employees, directors and vendors 255     255     255  
Proceeds from sale of common stock and pre-funded warrants, net of offering costs 7,913   $ 5 7,908     7,913  
Proceeds from sale of common stock and pre-funded warrants, net of offering costs, shares     5,027          
Common stock issued upon exercise of common stock warrants              
Common stock issued upon exercise of common stock warrants, shares     12          
Foreign currency translation adjustment (217)       (217)   (217)  
Net loss (5,649)         (5,291) (5,291) (358)
Balances at Dec. 31, 2016 $ 4,135 $ 49 $ 183,667 $ (171) $ (179,040) $ 4,505 $ (370)
Balances, shares at Dec. 31, 2016   83 48,845